Report Cover

Global Meningococcal Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027


Meningococcal vaccine refers to any of the vaccines used to prevent infection by Neisseria meningitides. The vaccines are between 85 and 100% effective for at least two years. They result in a decrease in meningitis and sepsis among populations where they are widely used. They are given either by injection into a muscle or just under the skin.
Global Meningococcal Vaccine key players include GSK, SANOFI PASTEUR S.A, Norvatis, Crucell, Medimmune, etc. Global top five players hold a share about 80%.
Europe is the largest market, with a share about 45%, followed by North America and China, having a total share about 40 percent.
In terms of product, Polysaccharide Meningtitis AC is the largest segment, with a share about 95%. And in terms of application, the largest application is 6 Months-15Year, followed by over 3 Year, over 2 Year, over 3 Months.

Market Analysis and Insights: Global Meningococcal Vaccine Market
In 2020, the global Meningococcal Vaccine market size was US$ 251 million and it is expected to reach US$ 339.2 million by the end of 2027, with a CAGR of 4.4% during 2021-2027.
Global Meningococcal Vaccine Scope and Market Size
Meningococcal Vaccine market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Meningococcal Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2016-2027.

Segment by Type, the Meningococcal Vaccine market is segmented into
    Meningtits A
    Polysaccharide Meningtitis AC
    Meningitis ACYW

Segment by Application, the Meningococcal Vaccine market is segmented into
    6 Months-15Year
    over 3 Year
    over 2 Year
    over 3 Months

Regional and Country-level Analysis:
    North America
        United States
        Canada
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Southeast Asia
        Australia
        Rest of Asia-Pacific
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    Latin America
        Mexico
        Brazil
        Rest of Latin America
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE
        Rest of MEA

Competitive Landscape and Meningococcal Vaccine Market Share Analysis
Meningococcal Vaccine market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2016-2021. Details included are company description, major business, Meningococcal Vaccine product introduction, recent developments, Meningococcal Vaccine sales by region, type, application and by sales channel.

The major companies include:
    Novartis
    GSK
    Merck
    CSL
    Baxter
    JN International Medical Corporation
    Serum Institute of India
    Bio-Med
    China National Biotec Group
    Hualan Bio
    Walvax
    Zhifei
1 Study Coverage
    1.1 Meningococcal Vaccine Product Introduction
    1.2 Market by Type
        1.2.1 Global Meningococcal Vaccine Market Size Growth Rate by Type
        1.2.2 Meningtits A
        1.2.3 Polysaccharide Meningtitis AC
        1.2.4 Meningitis ACYW
    1.3 Market by Application
        1.3.1 Global Meningococcal Vaccine Market Size Growth Rate by Application
        1.3.2 6 Months-15Year
        1.3.3 over 3 Year
        1.3.4 over 2 Year
        1.3.5 over 3 Months
    1.4 Study Objectives
    1.5 Years Considered

2 Executive Summary
    2.1 Global Meningococcal Vaccine Market Size Estimates and Forecasts
        2.1.1 Global Meningococcal Vaccine Revenue 2016-2027
        2.1.2 Global Meningococcal Vaccine Sales 2016-2027
    2.2 Meningococcal Vaccine Market Size by Region: 2021 Versus 2027
    2.3 Meningococcal Vaccine Sales by Region (2016-2027)
        2.3.1 Global Meningococcal Vaccine Sales by Region: 2016-2021
        2.3.2 Global Meningococcal Vaccine Sales Forecast by Region (2022-2027)
        2.3.3 Global Meningococcal Vaccine Sales Market Share by Region (2016-2027)
    2.4 Meningococcal Vaccine Market Estimates and Projections by Region (2022-2027)
        2.4.1 Global Meningococcal Vaccine Revenue by Region: 2016-2021
        2.4.2 Global Meningococcal Vaccine Revenue Forecast by Region (2022-2027)
        2.4.3 Global Meningococcal Vaccine Revenue Market Share by Region (2016-2027)

3 Global Meningococcal Vaccine by Manufacturers
    3.1 Global Top Meningococcal Vaccine Manufacturers by Sales
        3.1.1 Global Meningococcal Vaccine Sales by Manufacturer (2016-2021)
        3.1.2 Global Meningococcal Vaccine Sales Market Share by Manufacturer (2016-2021)
    3.2 Global Top Meningococcal Vaccine Manufacturers by Revenue
        3.2.1 Global Meningococcal Vaccine Revenue by Manufacturer (2016-2021)
        3.2.2 Global Meningococcal Vaccine Revenue Share by Manufacturer (2016-2021)
    3.3 Global Meningococcal Vaccine Price by Manufacturer (2016-2021)
    3.4 Competitive Landscape
        3.4.1 Key Meningococcal Vaccine Manufacturers Covered: Ranking by Revenue
        3.4.2 Global Meningococcal Vaccine Market Concentration Ratio (CR5 and HHI) & (2016-2021)
        3.4.3 Global Meningococcal Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.5 Global Meningococcal Vaccine Manufacturing Base Distribution, Product Type
        3.5.1 Meningococcal Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
        3.5.2 Manufacturers Meningococcal Vaccine Product Type
        3.5.3 Date of International Manufacturers Enter into Meningococcal Vaccine Market
    3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Company Profiles
    4.1 Novartis
        4.1.1 Novartis Corporation Information
        4.1.2 Novartis Description, Business Overview
        4.1.3 Novartis Meningococcal Vaccine Products Offered
        4.1.4 Novartis Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
        4.1.5 Novartis Meningococcal Vaccine Revenue by Product
        4.1.6 Novartis Meningococcal Vaccine Revenue by Application
        4.1.7 Novartis Meningococcal Vaccine Revenue by Geographic Area
        4.1.8 Novartis Meningococcal Vaccine Revenue by Sales Channel
        4.1.9 Novartis Recent Development
    4.2 GSK
        4.2.1 GSK Corporation Information
        4.2.2 GSK Description, Business Overview
        4.2.3 GSK Meningococcal Vaccine Products Offered
        4.2.4 GSK Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
        4.2.5 GSK Meningococcal Vaccine Revenue by Product
        4.2.6 GSK Meningococcal Vaccine Revenue by Application
        4.2.7 GSK Meningococcal Vaccine Revenue by Geographic Area
        4.2.8 GSK Meningococcal Vaccine Revenue by Sales Channel
        4.2.9 GSK Recent Development
    4.3 Merck
        4.3.1 Merck Corporation Information
        4.3.2 Merck Description, Business Overview
        4.3.3 Merck Meningococcal Vaccine Products Offered
        4.3.4 Merck Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
        4.3.5 Merck Meningococcal Vaccine Revenue by Product
        4.3.6 Merck Meningococcal Vaccine Revenue by Application
        4.3.7 Merck Meningococcal Vaccine Revenue by Geographic Area
        4.3.8 Merck Meningococcal Vaccine Revenue by Sales Channel
        4.3.9 Merck Recent Development
    4.4 CSL
        4.4.1 CSL Corporation Information
        4.4.2 CSL Description, Business Overview
        4.4.3 CSL Meningococcal Vaccine Products Offered
        4.4.4 CSL Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
        4.4.5 CSL Meningococcal Vaccine Revenue by Product
        4.4.6 CSL Meningococcal Vaccine Revenue by Application
        4.4.7 CSL Meningococcal Vaccine Revenue by Geographic Area
        4.4.8 CSL Meningococcal Vaccine Revenue by Sales Channel
        4.4.9 CSL Recent Development
    4.5 Baxter
        4.5.1 Baxter Corporation Information
        4.5.2 Baxter Description, Business Overview
        4.5.3 Baxter Meningococcal Vaccine Products Offered
        4.5.4 Baxter Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
        4.5.5 Baxter Meningococcal Vaccine Revenue by Product
        4.5.6 Baxter Meningococcal Vaccine Revenue by Application
        4.5.7 Baxter Meningococcal Vaccine Revenue by Geographic Area
        4.5.8 Baxter Meningococcal Vaccine Revenue by Sales Channel
        4.5.9 Baxter Recent Development
    4.6 JN International Medical Corporation
        4.6.1 JN International Medical Corporation Corporation Information
        4.6.2 JN International Medical Corporation Description, Business Overview
        4.6.3 JN International Medical Corporation Meningococcal Vaccine Products Offered
        4.6.4 JN International Medical Corporation Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
        4.6.5 JN International Medical Corporation Meningococcal Vaccine Revenue by Product
        4.6.6 JN International Medical Corporation Meningococcal Vaccine Revenue by Application
        4.6.7 JN International Medical Corporation Meningococcal Vaccine Revenue by Geographic Area
        4.6.8 JN International Medical Corporation Recent Development
    4.7 Serum Institute of India
        4.7.1 Serum Institute of India Corporation Information
        4.7.2 Serum Institute of India Description, Business Overview
        4.7.3 Serum Institute of India Meningococcal Vaccine Products Offered
        4.7.4 Serum Institute of India Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
        4.7.5 Serum Institute of India Meningococcal Vaccine Revenue by Product
        4.7.6 Serum Institute of India Meningococcal Vaccine Revenue by Application
        4.7.7 Serum Institute of India Meningococcal Vaccine Revenue by Geographic Area
        4.7.8 Serum Institute of India Recent Development
    4.8 Bio-Med
        4.8.1 Bio-Med Corporation Information
        4.8.2 Bio-Med Description, Business Overview
        4.8.3 Bio-Med Meningococcal Vaccine Products Offered
        4.8.4 Bio-Med Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
        4.8.5 Bio-Med Meningococcal Vaccine Revenue by Product
        4.8.6 Bio-Med Meningococcal Vaccine Revenue by Application
        4.8.7 Bio-Med Meningococcal Vaccine Revenue by Geographic Area
        4.8.8 Bio-Med Recent Development
    4.9 China National Biotec Group
        4.9.1 China National Biotec Group Corporation Information
        4.9.2 China National Biotec Group Description, Business Overview
        4.9.3 China National Biotec Group Meningococcal Vaccine Products Offered
        4.9.4 China National Biotec Group Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
        4.9.5 China National Biotec Group Meningococcal Vaccine Revenue by Product
        4.9.6 China National Biotec Group Meningococcal Vaccine Revenue by Application
        4.9.7 China National Biotec Group Meningococcal Vaccine Revenue by Geographic Area
        4.9.8 China National Biotec Group Recent Development
    4.10 Hualan Bio
        4.10.1 Hualan Bio Corporation Information
        4.10.2 Hualan Bio Description, Business Overview
        4.10.3 Hualan Bio Meningococcal Vaccine Products Offered
        4.10.4 Hualan Bio Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
        4.10.5 Hualan Bio Meningococcal Vaccine Revenue by Product
        4.10.6 Hualan Bio Meningococcal Vaccine Revenue by Application
        4.10.7 Hualan Bio Meningococcal Vaccine Revenue by Geographic Area
        4.10.8 Hualan Bio Recent Development
    4.11 Walvax
        4.11.1 Walvax Corporation Information
        4.11.2 Walvax Description, Business Overview
        4.11.3 Walvax Meningococcal Vaccine Products Offered
        4.11.4 Walvax Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
        4.11.5 Walvax Meningococcal Vaccine Revenue by Product
        4.11.6 Walvax Meningococcal Vaccine Revenue by Application
        4.11.7 Walvax Meningococcal Vaccine Revenue by Geographic Area
        4.11.8 Walvax Recent Development
    4.12 Zhifei
        4.12.1 Zhifei Corporation Information
        4.12.2 Zhifei Description, Business Overview
        4.12.3 Zhifei Meningococcal Vaccine Products Offered
        4.12.4 Zhifei Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
        4.12.5 Zhifei Meningococcal Vaccine Revenue by Product
        4.12.6 Zhifei Meningococcal Vaccine Revenue by Application
        4.12.7 Zhifei Meningococcal Vaccine Revenue by Geographic Area
        4.12.8 Zhifei Recent Development

5 Breakdown Data by Type
    5.1 Global Meningococcal Vaccine Sales by Type (2016-2027)
        5.1.1 Global Meningococcal Vaccine Sales by Type (2016-2021)
        5.1.2 Global Meningococcal Vaccine Sales Forecast by Type (2022-2027)
        5.1.3 Global Meningococcal Vaccine Sales Market Share by Type (2016-2027)
    5.2 Global Meningococcal Vaccine Revenue Forecast by Type (2016-2027)
        5.2.1 Global Meningococcal Vaccine Revenue by Type (2016-2021)
        5.2.2 Global Meningococcal Vaccine Revenue Forecast by Type (2022-2027)
        5.2.3 Global Meningococcal Vaccine Revenue Market Share by Type (2016-2027)
    5.3 Meningococcal Vaccine Average Selling Price (ASP) by Type (2016-2027)

6 Breakdown Data by Application
    6.1 Global Meningococcal Vaccine Sales by Application (2016-2027)
        6.1.1 Global Meningococcal Vaccine Sales by Application (2016-2021)
        6.1.2 Global Meningococcal Vaccine Sales Forecast by Application (2022-2027)
        6.1.3 Global Meningococcal Vaccine Sales Market Share by Application (2016-2027)
    6.2 Global Meningococcal Vaccine Revenue Forecast by Application (2016-2027)
        6.2.1 Global Meningococcal Vaccine Revenue by Application (2016-2021)
        6.2.2 Global Meningococcal Vaccine Revenue Forecast by Application (2022-2027)
        6.2.3 Global Meningococcal Vaccine Revenue Market Share by Application (2016-2027)
    6.3 Meningococcal Vaccine Average Selling Price (ASP) by Application (2016-2027)

7 North America
    7.1 North America Meningococcal Vaccine Market Size YoY Growth 2016-2027
    7.2 North America Meningococcal Vaccine Market Facts & Figures by Country
        7.2.1 North America Meningococcal Vaccine Sales by Country (2016-2027)
        7.2.2 North America Meningococcal Vaccine Revenue by Country (2016-2027)
    7.3 North America Meningococcal Vaccine Sales by Type
    7.4 North America Meningococcal Vaccine Sales by Application

8 Asia-Pacific
    8.1 Asia-Pacific Meningococcal Vaccine Market Size YoY Growth 2016-2027
    8.2 Asia-Pacific Meningococcal Vaccine Market Facts & Figures by Region
        8.2.1 Asia-Pacific Meningococcal Vaccine Sales by Region (2016-2027)
        8.2.2 Asia-Pacific Meningococcal Vaccine Revenue by Region (2016-2027)
    8.3 Asia-Pacific Meningococcal Vaccine Sales by Type
    8.4 Asia-Pacific Meningococcal Vaccine Sales by Application

9 Europe
    9.1 Europe Meningococcal Vaccine Market Size YoY Growth 2016-2027
    9.2 Europe Meningococcal Vaccine Market Facts & Figures by Country
        9.2.1 Europe Meningococcal Vaccine Sales by Country (2016-2027)
        9.2.2 Europe Meningococcal Vaccine Revenue by Country (2016-2027)
    9.3 Europe Meningococcal Vaccine Sales by Type
    9.4 Europe Meningococcal Vaccine Sales by Application

10 Latin America
    10.1 Latin America Meningococcal Vaccine Market Size YoY Growth 2016-2027
    10.2 Latin America Meningococcal Vaccine Market Facts & Figures by Country
        10.2.1 Latin America Meningococcal Vaccine Sales by Country (2016-2027)
        10.2.2 Latin America Meningococcal Vaccine Revenue by Country (2016-2027)
    10.3 Latin America Meningococcal Vaccine Sales by Type
    10.4 Latin America Meningococcal Vaccine Sales by Application

11 Middle East and Africa
    11.1 Middle East and Africa Meningococcal Vaccine Market Size YoY Growth 2016-2027
    11.2 Middle East and Africa Meningococcal Vaccine Market Facts & Figures by Country
        11.2.1 Middle East and Africa Meningococcal Vaccine Sales by Country (2016-2027)
        11.2.2 Middle East and Africa Meningococcal Vaccine Revenue by Country (2016-2027)
    11.3 Middle East and Africa Meningococcal Vaccine Sales by Type
    11.4 Middle East and Africa Meningococcal Vaccine Sales by Application

12 Supply Chain and Sales Channel Analysis
    12.1 Meningococcal Vaccine Supply Chain Analysis
    12.2 Meningococcal Vaccine Key Raw Materials and Upstream Suppliers
    12.3 Meningococcal Vaccine Clients Analysis
    12.4 Meningococcal Vaccine Sales Channel and Sales Model Analysis
        12.4.1 Meningococcal Vaccine Distribution Channel Analysis: Indirect Sales VS Direct Sales
        12.4.2 Meningococcal Vaccine Distribution Channel Analysis: Online Sales VS Offline Sales
        12.4.3 Meningococcal Vaccine Distributors

13 Market Dynamics
    13.1 Meningococcal Vaccine Market Drivers
    13.2 Meningococcal Vaccine Market Opportunities
    13.3 Meningococcal Vaccine Market Challenges
    13.4 Meningococcal Vaccine Market Restraints
    13.5 Porter's Five Forces Analysis

14 Research Findings and Conclusion

15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables Table 1. Global Meningococcal Vaccine Market Size Growth Rate by Type (US$ Million): 2021 VS 2027 Table 2. Major Manufacturers of Meningtits A Table 3. Major Manufacturers of Polysaccharide Meningtitis AC Table 4. Major Manufacturers of Meningitis ACYW Table 5. Global Meningococcal Vaccine Market Size Growth by Application (US$ Million): 2021 VS 2027 Table 6. Global Meningococcal Vaccine Market Size by Region (US$ Million): 2021 VS 2027 Table 7. Global Meningococcal Vaccine Sales by Region (2016-2021) & (10K Pcs) Table 8. Global Meningococcal Vaccine Sales Forecast by Region (2022-2027) & (10K Pcs) Table 9. Global Meningococcal Vaccine Revenue by Region (2016-2021) & (US$ Million) Table 10. Global Meningococcal Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million) Table 11. Global Meningococcal Vaccine Sales by Manufacturer (2016-2021) & (10K Pcs) Table 12. Global Meningococcal Vaccine Sales Share by Manufacturer (2016-2021) Table 13. Meningococcal Vaccine Revenue by Manufacturer (2016-2021) & (US$ Million) Table 14. Meningococcal Vaccine Revenue Share by Manufacturer (2016-2021) Table 15. Key Manufacturers Meningococcal Vaccine Price (2016-2021) & (USD/Pcs) Table 16. Ranking of Global Top Meningococcal Vaccine Manufacturers by Revenue (US$ Million) in 2020 Table 17. Global Meningococcal Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 18. Global Meningococcal Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Meningococcal Vaccine as of 2020) Table 19. Meningococcal Vaccine Manufacturers Manufacturing Base Distribution and Headquarters Table 20. Manufacturers Meningococcal Vaccine Product Type Table 21. Date of International Manufacturers Enter into Meningococcal Vaccine Market Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans Table 23. Novartis Corporation Information Table 24. Novartis Description and Business Overview Table 25. Novartis Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 26. Novartis Meningococcal Vaccine Product Table 27. Novartis Meningococcal Vaccine Revenue (US$ Million) and Market Share by Product Table 28. Novartis Meningococcal Vaccine Revenue (US$ Million) and Market Share by Application Table 29. Novartis Meningococcal Vaccine Revenue (US$ Million) and Market Share by Geographic Area Table 30. Novartis Meningococcal Vaccine Revenue (US$ Million) and Market Share by Sales Channel Table 31. Novartis Recent Development Table 32. GSK Corporation Information Table 33. GSK Description and Business Overview Table 34. GSK Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 35. GSK Meningococcal Vaccine Product Table 36. GSK Meningococcal Vaccine Revenue (US$ Million) and Market Share by Product Table 37. GSK Meningococcal Vaccine Revenue (US$ Million) and Market Share by Application Table 38. GSK Meningococcal Vaccine Revenue (US$ Million) and Market Share by Geographic Area Table 39. GSK Meningococcal Vaccine Revenue (US$ Million) and Market Share by Sales Channel Table 40. GSK Recent Development Table 41. Merck Corporation Information Table 42. Merck Description and Business Overview Table 43. Merck Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 44. Merck Meningococcal Vaccine Product Table 45. Merck Meningococcal Vaccine Revenue (US$ Million) and Market Share by Product Table 46. Merck Meningococcal Vaccine Revenue (US$ Million) and Market Share by Application Table 47. Merck Meningococcal Vaccine Revenue (US$ Million) and Market Share by Geographic Area Table 48. Merck Meningococcal Vaccine Revenue (US$ Million) and Market Share by Sales Channel Table 49. Merck Recent Development Table 50. CSL Corporation Information Table 51. CSL Description and Business Overview Table 52. CSL Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 53. CSL Meningococcal Vaccine Product Table 54. CSL Meningococcal Vaccine Revenue (US$ Million) and Market Share by Product Table 55. CSL Meningococcal Vaccine Revenue (US$ Million) and Market Share by Application Table 56. CSL Meningococcal Vaccine Revenue (US$ Million) and Market Share by Geographic Area Table 57. CSL Meningococcal Vaccine Revenue (US$ Million) and Market Share by Sales Channel Table 58. CSL Recent Development Table 59. Baxter Corporation Information Table 60. Baxter Description and Business Overview Table 61. Baxter Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 62. Baxter Meningococcal Vaccine Product Table 63. Baxter Meningococcal Vaccine Revenue (US$ Million) and Market Share by Product Table 64. Baxter Meningococcal Vaccine Revenue (US$ Million) and Market Share by Application Table 65. Baxter Meningococcal Vaccine Revenue (US$ Million) and Market Share by Geographic Area Table 66. Baxter Meningococcal Vaccine Revenue (US$ Million) and Market Share by Sales Channel Table 67. Baxter Recent Development Table 68. JN International Medical Corporation Corporation Information Table 69. JN International Medical Corporation Description and Business Overview Table 70. JN International Medical Corporation Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 71. JN International Medical Corporation Meningococcal Vaccine Product Table 72. JN International Medical Corporation Meningococcal Vaccine Revenue (US$ Million) and Market Share by Product Table 73. JN International Medical Corporation Meningococcal Vaccine Revenue (US$ Million) and Market Share by Application Table 74. JN International Medical Corporation Meningococcal Vaccine Revenue (US$ Million) and Market Share by Geographic Area Table 75. JN International Medical Corporation Recent Development Table 76. Serum Institute of India Corporation Information Table 77. Serum Institute of India Description and Business Overview Table 78. Serum Institute of India Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 79. Serum Institute of India Meningococcal Vaccine Product Table 80. Serum Institute of India Meningococcal Vaccine Revenue (US$ Million) and Market Share by Product Table 81. Serum Institute of India Meningococcal Vaccine Revenue (US$ Million) and Market Share by Application Table 82. Serum Institute of India Meningococcal Vaccine Revenue (US$ Million) and Market Share by Geographic Area Table 83. Serum Institute of India Recent Development Table 84. Bio-Med Corporation Information Table 85. Bio-Med Description and Business Overview Table 86. Bio-Med Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 87. Bio-Med Meningococcal Vaccine Product Table 88. Bio-Med Meningococcal Vaccine Revenue (US$ Million) and Market Share by Product Table 89. Bio-Med Meningococcal Vaccine Revenue (US$ Million) and Market Share by Application Table 90. Bio-Med Meningococcal Vaccine Revenue (US$ Million) and Market Share by Geographic Area Table 91. Bio-Med Recent Development Table 92. China National Biotec Group Corporation Information Table 93. China National Biotec Group Description and Business Overview Table 94. China National Biotec Group Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 95. China National Biotec Group Meningococcal Vaccine Product Table 96. China National Biotec Group Meningococcal Vaccine Revenue (US$ Million) and Market Share by Product Table 97. China National Biotec Group Meningococcal Vaccine Revenue (US$ Million) and Market Share by Application Table 98. China National Biotec Group Meningococcal Vaccine Revenue (US$ Million) and Market Share by Geographic Area Table 99. China National Biotec Group Recent Development Table 100. Hualan Bio Corporation Information Table 101. Hualan Bio Description and Business Overview Table 102. Hualan Bio Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 103. Hualan Bio Meningococcal Vaccine Product Table 104. Hualan Bio Meningococcal Vaccine Revenue (US$ Million) and Market Share by Product Table 105. Hualan Bio Meningococcal Vaccine Revenue (US$ Million) and Market Share by Application Table 106. Hualan Bio Meningococcal Vaccine Revenue (US$ Million) and Market Share by Geographic Area Table 107. Hualan Bio Recent Development Table 108. Walvax Corporation Information Table 109. Walvax Description and Business Overview Table 110. Walvax Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 111. Walvax Meningococcal Vaccine Product Table 112. Walvax Meningococcal Vaccine Revenue (US$ Million) and Market Share by Product Table 113. Walvax Meningococcal Vaccine Revenue (US$ Million) and Market Share by Application Table 114. Walvax Meningococcal Vaccine Revenue (US$ Million) and Market Share by Geographic Area Table 115. Walvax Recent Development Table 116. Zhifei Corporation Information Table 117. Zhifei Description and Business Overview Table 118. Zhifei Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 119. Zhifei Meningococcal Vaccine Product Table 120. Zhifei Meningococcal Vaccine Revenue (US$ Million) and Market Share by Product Table 121. Zhifei Meningococcal Vaccine Revenue (US$ Million) and Market Share by Application Table 122. Zhifei Meningococcal Vaccine Revenue (US$ Million) and Market Share by Geographic Area Table 123. Zhifei Recent Development Table 124. Global Meningococcal Vaccine Sales by Type (2016-2021) & (10K Pcs) Table 125. Global Meningococcal Vaccine Sales Forecast by Type (2022-2027) & (10K Pcs) Table 126. Global Meningococcal Vaccine Revenue by Type (2016-2021) & (US$ Million) Table 127. Global Meningococcal Vaccine Revenue Forecast by Type (2022-2027) & (US$ Million) Table 128. Global Meningococcal Vaccine Sales by Application (2016-2021) & (10K Pcs) Table 129. Global Meningococcal Vaccine Sales Forecast by Application (2022-2027) & (10K Pcs) Table 130. Global Meningococcal Vaccine Revenue by Application (2016-2021) & (US$ Million) Table 131. Global Meningococcal Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million) Table 132. North America Meningococcal Vaccine Sales by Country (2016-2021) & (10K Pcs) Table 133. North America Meningococcal Vaccine Sales by Country (2022-2027) & (10K Pcs) Table 134. North America Meningococcal Vaccine Revenue by Country (2016-2021) & (US$ Million) Table 135. North America Meningococcal Vaccine Revenue by Country (2022-2027) & (US$ Million) Table 136. North America Meningococcal Vaccine Sales by Type (2016-2021) & (10K Pcs) Table 137. North America Meningococcal Vaccine Sales by Application (2016-2021) & (10K Pcs) Table 138. Asia-Pacific Meningococcal Vaccine Sales by Region (2016-2021) & (10K Pcs) Table 139. Asia-Pacific Meningococcal Vaccine Sales by Region (2022-2027) & (10K Pcs) Table 140. Asia-Pacific Meningococcal Vaccine Revenue by Region (2016-2027) & (US$ Million) Table 141. Asia-Pacific Meningococcal Vaccine Revenue by Region (2022-2027) & (US$ Million) Table 142. Asia-Pacific Meningococcal Vaccine Sales by Type (2016-2021) & (10K Pcs) Table 143. Asia-Pacific Meningococcal Vaccine Sales by Application (2016-2021) & (10K Pcs) Table 144. Europe Meningococcal Vaccine Sales by Country (2016-2021) & (10K Pcs) Table 145. Europe Meningococcal Vaccine Sales by Country (2022-2027) & (10K Pcs) Table 146. Europe Meningococcal Vaccine Revenue by Country (2016-2021) & (US$ Million) Table 147. Europe Meningococcal Vaccine Revenue by Country (2022-2027) & (US$ Million) Table 148. Europe Meningococcal Vaccine Sales by Type (2016-2021) & (10K Pcs) Table 149. Europe Meningococcal Vaccine Sales by Application (2016-2021) & (10K Pcs) Table 150. Latin America Meningococcal Vaccine Sales by Country (2016-2021) & (10K Pcs) Table 151. Latin America Meningococcal Vaccine Sales by Country (2022-2027) & (10K Pcs) Table 152. Latin America Meningococcal Vaccine Revenue by Country (2016-2021) & (US$ Million) Table 153. Latin America Meningococcal Vaccine Revenue by Country (2022-2027) & (US$ Million) Table 154. Latin America Meningococcal Vaccine Sales by Type (2016-2021) & (10K Pcs) Table 155. Latin America Meningococcal Vaccine Sales by Application (2016-2021) & (10K Pcs) Table 156. Middle East and Africa Meningococcal Vaccine Sales by Country (2016-2021) & (10K Pcs) Table 157. Middle East and Africa Meningococcal Vaccine Sales by Country (2022-2027) & (10K Pcs) Table 158. Middle East and Africa Meningococcal Vaccine Revenue by Country (2016-2021) & (US$ Million) Table 159. Middle East and Africa Meningococcal Vaccine Revenue by Country (2022-2027) & (US$ Million) Table 160. Middle East and Africa Meningococcal Vaccine Sales by Type (2016-2021) & (10K Pcs) Table 161. Middle East and Africa Meningococcal Vaccine Sales by Application (2016-2021) & (10K Pcs) Table 162. Meningococcal Vaccine Key Raw Materials, Industry Status and Trend Table 163. Meningococcal Vaccine Key Raw Materials and Upstream Suppliers Table 164. Meningococcal Vaccine Clients Status and Trend Table 165. Meningococcal Vaccine Typical Clients Table 166. Meningococcal Vaccine Distributors Table 167. Key Drivers: Impact Analysis (2022-2027) Table 168. Meningococcal Vaccine Market Drivers Table 169. Meningococcal Vaccine Market Opportunities Table 170. Meningococcal Vaccine Market Challenges Table 171. Meningococcal Vaccine Market Restraints Table 172. Meningococcal Vaccine Porter's Five Forces Analysis Table 173. Research Programs/Design for This Report Table 174. Key Data Information from Secondary Sources Table 175. Key Data Information from Primary Sources List of Figures Figure 1. Meningococcal Vaccine Product Picture Figure 2. Global Meningococcal Vaccine Sales Market Share by Type in 2021 & 2027 Figure 3. Meningtits A Product Picture Figure 4. Polysaccharide Meningtitis AC Product Picture Figure 5. Meningitis ACYW Product Picture Figure 6. Global Meningococcal Vaccine Sales Market Share by Application in 2021 & 2027 Figure 7. 6 Months-15Year Examples Figure 8. over 3 Year Examples Figure 9. over 2 Year Examples Figure 10. over 3 Months Examples Figure 11. Meningococcal Vaccine Report Years Considered Figure 12. Global Meningococcal Vaccine Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Meningococcal Vaccine Market Size 2016-2027 (US$ Million) Figure 14. Global Meningococcal Vaccine Sales 2016-2027 (K Units) Figure 15. Global Meningococcal Vaccine Market Size Market Share by Region: 2021 Versus 2027 Figure 16. Global Meningococcal Vaccine Sales Market Share Forecast by Region (2016-2027) Figure 17. Global Meningococcal Vaccine Revenue Market Share by Region (2016-2027) Figure 18. Global Meningococcal Vaccine Sales Share by Manufacturer in 2020 Figure 19. Meningococcal Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 20. Global Meningococcal Vaccine Sales Market Share Forecast by Type (2016-2027) Figure 21. Global Meningococcal Vaccine Revenue Market Share Forecast by Type (2016-2027) Figure 22. Meningococcal Vaccine Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit) Figure 23. Global Meningococcal Vaccine Sales Market Share Forecast by Application (2016-2027) Figure 24. Global Meningococcal Vaccine Revenue Market Share Forecast by Application (2016-2027) Figure 25. Meningococcal Vaccine Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit) Figure 26. North America Meningococcal Vaccine Revenue 2016-2027 (US$ Million) Figure 27. North America Meningococcal Vaccine Sales Market Share by Type (2016-2021) Figure 28. North America Meningococcal Vaccine Sales Market Share by Application (2016-2021) Figure 29. Asia-Pacific Meningococcal Vaccine Revenue 2016-2027 (US$ Million) Figure 30. Asia-Pacific Meningococcal Vaccine Sales Market Share by Region (2016-2027) Figure 31. Asia-Pacific Meningococcal Vaccine Revenue Market Share by Region (2016-2027) Figure 32. Asia-Pacific Meningococcal Vaccine Sales Market Share by Type (2016-2021) Figure 33. Asia-Pacific Meningococcal Vaccine Sales Market Share by Application (2016-2021) Figure 34. Europe Meningococcal Vaccine Revenue Growth Rate 2016-2027 (US$ Million) Figure 35. Europe Meningococcal Vaccine Sales Market Share by Country (2016-2027) Figure 36. Europe Meningococcal Vaccine Revenue Market Share by Country (2016-2027) Figure 37. Europe Meningococcal Vaccine Sales Market Share by Type (2016-2021) Figure 38. Europe Meningococcal Vaccine Sales Market Share by Application (2016-2021) Figure 39. Latin America Meningococcal Vaccine Revenue Growth Rate 2016-2027 (US$ Million) Figure 40. Latin America Meningococcal Vaccine Sales Market Share by Country (2016-2027) Figure 41. Latin America Meningococcal Vaccine Revenue Market Share by Country (2016-2021) Figure 42. Latin America Meningococcal Vaccine Sales Market Share by Type (2016-2021) Figure 43. Latin America Meningococcal Vaccine Sales Market Share by Application (2016-2021) Figure 44. Middle East and Africa Meningococcal Vaccine Revenue Growth Rate 2016-2027 (US$ Million) Figure 45. Middle East and Africa Meningococcal Vaccine Sales Market Share by Country (2016-2027) Figure 46. Middle East and Africa Meningococcal Vaccine Revenue Market Share by Country (2016-2027) Figure 47. Middle East and Africa Meningococcal Vaccine Sales Market Share by Type (2016-2021) Figure 48. Middle East and Africa Meningococcal Vaccine Sales Market Share by Application (2016-2021) Figure 49. Meningococcal Vaccine Supply Chain (Upstream and Downstream Market) Figure 50. Global Production Market Share of Meningococcal Vaccine Raw Materials by Region in 2020 Figure 51. Meningococcal Vaccine Distribution Channels Figure 52. Global Meningococcal Vaccine Percentage 2016-2027: Indirect Sales VS Direct Sales Figure 53. Global Meningococcal Vaccine Percentage 2016-2027: Online Sales VS Offline Sales Figure 54. Porter's Five Forces Analysis Figure 55. Bottom-up and Top-down Approaches for This Report Figure 56. Data Triangulation Figure 57. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us